Learning Objectives:

1. Be able to determine the risk of malignancy of an adrenal mass and any adrenal hormone excess that would support a “primary” adrenal process: functional and/or anatomical / benign or malignant.

2. Understand the role of genetics in the pathobiology of adrenal cancer and to discuss how such knowledge is transforming how we care for our patients.

Session date: 
01/30/2023 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Gary Hammer, M.D., Ph.D.